European Congress of Nuclear Medicine EANM 2018

The European Congress of 2018 of the EANM will take place in Düsseldorf from October 13 to 17.

More information

Posted in Congress | Leave a comment

FDA approves new treatment for certain digestive tract cancers

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This is the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of GEP-NETs. Lutathera is indicated for adult patients with somatostatin receptor-positive GEP-NETs.

More information

Posted in News | Leave a comment

International Conference on Nuclear Medicine and Radiation Therapy

International Conference on Nuclear Medicine and Radiation Therapy

Madrid, Spain July 16-17, 2018


Posted in Congress | Leave a comment

19th European Symposium on Radiopharmacy and Radiopharmaceuticals

19th European Symposium on Radiopharmacy and Radiopharmaceuticals.

April 05-08, 2018 • Groningen, Netherlands



Posted in Congress | Leave a comment

New version of Radiolab

A new version of Radiolab -application for comprehensive management of hospital radiopharmacies- is now available at Radiolab 4.0 includes among others the following new features:

  • Addition of small, medium and large labels for radioactive products and cold kits.
  • Addition of Ga-68 generator in the Generators module.
  • Each user can change their own password in the Maintenance module without relying on the Administrator. This new functionality is only active in the registered versions of Radiolab.
  • The activity of the radionuclides in the Waste module is now shown in mCi and Bq. Only those radionuclides having at least a residual activity of 0.01 Bq are shown.
  • The user who made the last backup of the Radiolab database is registered, and also when and where they made the backup is registered.
  • Effective doses are automatically calculated at two different times. Firstly, they are automatically calculated when you import the prescriptions in the Prescriptions section of the Dispensing module. And secondly, each effective dose is automatically recalculated when the administered radiopharmaceutical, its activity or the patient’s age is modified in the Dispensing module.
  • The Dosimetry section has been included in the Traceability module, which allows the reporting of the effective doses of all radiopharmaceuticals administered to every patient, as well as the cumulative total effective dose of all of them.

Posted in Information | Leave a comment


30th Annual Meeting of the European Association of Nuclear Medicine.

More information

Posted in Congress | Leave a comment

Certificate of Advanced Studies in Radiopharmaceutical Chemistry/Radiopharmacy

Postgraduate course to obtain the “Certificate of Advanced Studies in Radiopharmaceutical Chemistry/Radiopharmacy”.

August 28-September 8, 2017. Faculty of Pharmacy, University of Ljubljana, Slovenia More information

Posted in Training | Leave a comment

SNMMI 2017 Annual Meeting

The Society of Nuclear Medicine & Molecular Imaging (SNMMI) is now accepting abstracts for the SNMMI 2017 Annual Meeting, June 10-14, 2017 in Denver, CO.


Posted in Sin categoría | Leave a comment

XIV Turku PET Symposium

The XIV Turku PET Symposium will be held on 27 – 30 May 2017 in Turku, Finland

Posted in Congress | Leave a comment

Consensus nomenclature rules for radiopharmaceutical chemistry


In 2015, a Working Group (WG) on Nomenclature in Radiopharmaceutical Chemistry and related areas was created to clarify terms and to generate consensus on the use of a standardized nomenclature in our field. This WG consists of members from several countries (Canada, Sweden, Germany, United States, Japan, United Kingdom, Korea, Austria, etc.) as well as active members of relevant scientific societies (European Association of Nuclear Medicine, Radiopharmaceutical Sciences, Society of Nuclear Medicine, Society of Radiopharmacology, etc.).
After conducting a global survey using a questionnaire, the WG has prepared a document (30-11-16-consensus-nomenclature-rules) and has opened a consultation period thereon to provide comments, as some problems and terms have not yet been resolved. Suggestions for topics not covered in this document are also welcome. Any comments on this document may be sent to Heinz H. Coenen ( and Antony Gee ( before 31 January 2017. After this deadline, opinions expressed during the consultation period will be discussed and the resulting consensus will be incorporated into a pre-final document, which will be republished on the SRS website. The outstanding issues will be discussed at the 22nd meeting of the ISRS in Dresden (14-19 May 2017). Subsequently, the resulting consensus naming guidelines will be published in an appropriate journal as a reference source and as a basis for discussion with journal editors, IUPACs and key stakeholders beyond the immediate peer group of the WG.

Posted in Guidance | Leave a comment